Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CD44 | P16070 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.38 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10947387 | 0.86 | CYP3A4 (0.52) | CYP3A4ALDH1A1THRBTSHRTP53 | |
| SCHEMBL345827 | 0.86 | CYP3A4 (0.50) | CYP3A4ALDH1A1THRBTSHRTP53 | |
| SCHEMBL14872332 | 0.82 | CYP3A4 (0.46) | CYP3A4ALDH1A1THRBTSHRTP53 | |
| SCHEMBL29739453 | 0.82 | CYP3A4 (0.46) | CYP3A4ALDH1A1THRBTSHRTP53 | |
| SCHEMBL3786627 | 0.82 | THRB (0.54) | CYP3A4ALDH1A1THRBTSHRTP53 | |
| SCHEMBL24616492 | 0.82 | CYP3A4 (0.52) | CYP3A4ALDH1A1THRBTSHRTP53 | |
| SCHEMBL20263523 | 0.78 | CYP3A4 (0.42) | CYP3A4ALDH1A1THRBTSHRTP53 | |
| SCHEMBL27503497 | 0.77 | ALDH1A1 (0.41) | CYP3A4ALDH1A1THRBTSHRTP53 | |
| SCHEMBL15277639 | 0.77 | ALDH1A1 (0.41) | CYP3A4ALDH1A1THRBTSHRTP53 | |
| SCHEMBL27427348 | 0.75 | CYP3A4 (0.39) | CYP3A4ALDH1A1THRBTSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118561708-A | Benzoyl bacteria method for synthesizing amine | 湖北晟康化工有限公司 | 2024-08-30 | — | — | CN | claimed |
| US-12528761-B2 | Thyromimetics | AUTOBAHN THERAPEUTICS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20250171462-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | TENVIE THERAPEUTICS, INC. | 2025-05-29 | — | — | US | disclosed |
| EP-4486722-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | Nico Therapeutics, Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| CN-119137101-A | Compounds, compositions, and methods | 尼科治疗有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-118465140-B | Rapid detection method for aromatic nitrogen-containing disinfection byproducts in biological tissues | 同济大学 | 2024-11-05 | — | — | CN | disclosed |
| CN-118561708-A | Benzoyl bacteria method for synthesizing amine | 湖北晟康化工有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118465140-A | Rapid detection method for aromatic nitrogen-containing disinfection byproducts in biological tissues | 同济大学 | 2024-08-09 | — | — | CN | disclosed |
| WO-2023168298-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | DENALI THERAPEUTICS INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023168298-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | DENALI THERAPEUTICS INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| US-4351959-A | Process for preparation of anilines substituted by chlorine in the meta-position | RHONE-POULENC AGROCHIMIE (FR) | 1982-09-28 | — | — | US | disclosed |
| US-4340759-A | Process for the preparation of anilines substituted by chlorine in the meta-position | RHONE-POULENC AGROCHIMIE (FR) | 1982-07-20 | — | — | US | disclosed |
| EP-0051782-A1 | Process for the manufacture of m-halogenated anilines | BAYER AG (DE) | 1982-05-19 | — | — | EP | disclosed |
| US-4324914-A | Process for preparation of anilines substituted by chlorine in the meta-position | RHONE-POULENC AGROCHIMIE (FR) | 1982-04-13 | — | — | US | disclosed |
| US-4233055-A | Quaternary ammonioalkanecarboxylic acid anilides as plant growth influencing agents | CIBA-GEIGY CORPORATION (US) | 1980-11-11 | — | — | US | disclosed |
| US-4193937-A | DECHLORINATION OF CHLOROANILINES, SELECTIVE HYDROGENATION CATALYSTS OF NOBLE METAL AND SULFUR | BAYER AKTIENGESELLSCHAFT (DE) | 1980-03-18 | — | — | US | disclosed |
| US-4141718-A | ANTIGROWTH AGENTS FOR PLANTS | CIBA-GEIGY CORPORATION (US) | 1979-02-27 | — | — | US | disclosed |
| US-4139621-A | TRANQUILIZERS | BEECHAM GROUP LIMITED (GB) | 1979-02-13 | — | — | US | disclosed |
| US-4085141-A | Process for the preparation of anilines meta-substituted by chlorine | BAYER AKTIENGESELLSCHAFT (DT) | 1978-04-18 | — | — | US | disclosed |
| US-3962336-A | Process for the preparation of 5-chloro-2-toluidine | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171462-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | SARM1, SARS1, TIAM1 | CYP3A4 4262/4885ALDH1A1 4115/4885THRB 1874/4885 |
| US-12528761-B2 | Thyromimetics | TSHR, THRB, TTR | CYP3A4 1632/4885ALDH1A1 1038/4885THRB 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.